Exchange: NASDAQ·Updated 07:34 PM EDT
MCRB logo

MCRBSeres Therapeutics Inc

$4.97
$0.265
(5.07%)
Today
Closed $4.97
$0.025
(0.50%)
After Hours
EarningsAug 5
Mkt Cap$48.08M
Vol84,528.00
News
all
press releases
Seres Therapeutics Posts Early Data for Cancer Therapy Complication
Seres Therapeutics reported early SER-155 data, with 80% of patients achieving steroid-free clinical response by Day 15.read more...
Benzinga
More News
Seres Therapeutics (NASDAQ:MCRB) Releases Quarterly Earnings Results, Misses Estimates By $0.20 EPS
Seres Therapeutics (NASDAQ:MCRB - Get Free Report) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($2.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.88) by ($0.20). The company had revenue of $0.36 million during the...
MarketBeat
Seres Therapeutics (MCRB) Projected to Post Quarterly Earnings on Wednesday
Seres Therapeutics (NASDAQ:MCRB) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 200 Day Moving Average - Here's What Happened
Seres Therapeutics (NASDAQ:MCRB) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell...
MarketBeat
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving Average - Here's What Happened
Seres Therapeutics (NASDAQ:MCRB) Shares Cross Below 50 Day Moving Average - Here's Why...
MarketBeat
Seres Therapeutics, Inc. (NASDAQ:MCRB) Short Interest Down 15.4% in February
Seres Therapeutics, Inc. (NASDAQ:MCRB - Get Free Report) was the recipient of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling...
MarketBeat
Seres Therapeutics (NASDAQ:MCRB) Receives Buy Rating from Canaccord Genuity Group
Canaccord Genuity Group restated a "buy" rating and issued a $22.00 price target on shares of Seres Therapeutics in a research report on Friday...
MarketBeat
Seres Therapeutics (NASDAQ:MCRB) Issues Earnings Results
Seres Therapeutics (NASDAQ:MCRB - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported ($1.76) earnings per share for the quarter, beating analysts...
MarketBeat
Seres Therapeutics (MCRB) Projected to Post Earnings on Thursday
Seres Therapeutics (NASDAQ:MCRB) will be releasing its Status update earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat
Seres Therapeutics (NASDAQ:MCRB) Shares Cross Below 50-Day Moving Average - What's Next?
Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving Average - Should You Sell...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.